EDENOR current report, Q4 FY2008

EDENOR Form 6-K Summary: Share Repurchase Activity

Business Context and Reporting Period

This Form 6-K filing by Empresa Distribuidora y Comercializadora Norte S.A. (EDENOR) reports on a specific corporate action rather than general operating results. The report covers the period from December 1, 2008, to December 5, 2008, and was filed on December 9, 2008. The filing complies with Argentine securities regulations (CNV and BCBA) regarding the company's ongoing share repurchase program.

Key Financial Metrics

The filing details a single transaction involving the repurchase of Class B common stock. No revenue, profit, cash flow, or debt metrics are provided in this document.

Metric Value
Shares Repurchased 874,000
Share Class Class B Common Stock
Average Price Paid Ps. 0.682 per share
Price Range Ps. 0.670 (Min) to Ps. 0.699 (Max)
Total Cost Ps. 595,694.86
Broker/Dealer Raymond James

Material Changes

This filing does not provide comparative data against prior periods. It serves as a weekly disclosure of share buyback activity executed under an existing program. The transaction represents a reduction in outstanding shares and a cash outflow of approximately Ps. 595,695.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or outlook for future operations. It does not disclose specific risks or contingencies beyond the standard execution of the share repurchase program. The transaction was executed on December 1, 2008, and reported within the required weekly timeframe.

Investor Verification Checklist

  • Verify the total number of shares authorized for repurchase under the current program to assess remaining capacity.
  • Confirm the company's cash position to ensure the repurchase program does not impact liquidity or operational funding.
  • Review the par value (Ps. 1.00) versus the repurchase price (Ps. 0.682) to understand the discount at which shares were acquired.
  • Check subsequent filings to determine if the repurchase program continued in the following weeks.